2019
Surgical Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA Guideline Amendment 2019.
Foster H, Dahm P, Kohler TS, Lerner LB, Parsons JK, Wilt TJ, McVary K. Surgical Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA Guideline Amendment 2019. Journal Of Urology 2019, 202: 592-598. PMID: 31059668, DOI: 10.1097/ju.0000000000000319.Peer-Reviewed Original ResearchConceptsBenign prostatic hyperplasiaLUTS/benign prostatic hyperplasiaLower urinary tract symptomsUrinary tract symptomsTract symptomsSurgical managementProstatic hyperplasiaMale lower urinary tract symptomsEvidence-based surgical managementAssociated treatment algorithmFuture surgical optionsPre-operative testsInvasive surgical therapiesEvidence-based recommendationsQuality of lifeSufficient evidenceHealthcare of patientsLUTS increasesSurgical therapyConditional recommendationSurgical optionsTreatment algorithmCochrane LibraryBody of evidenceImportant diagnosis
2000
Cystic pelvic pathology presenting as falsely elevated postvoid residual urine measured by portable ultrasound bladder scanning: report of 3 cases and review of the literature
Cooperberg M, Chambers S, Rutherford T, Foster H. Cystic pelvic pathology presenting as falsely elevated postvoid residual urine measured by portable ultrasound bladder scanning: report of 3 cases and review of the literature. Urology 2000, 55: 590. PMID: 10754180, DOI: 10.1016/s0090-4295(99)00565-8.Peer-Reviewed Original ResearchConceptsUrine volumePost-void residual urine volumeElevated postvoid residual urinePostvoid residual urineResidual urine volumeLow urine volumeElevated PVRResidual urineRadiologic evaluationBladder scanningOvarian pathologySubsequent catheterizationUltrasound correlatesPelvic pathologyLower abdomenCystic pathologyPVR measurementElevated readingsPortable ultrasound deviceFurther evaluationPathologyPVRUltrasound deviceUltrasoundCatheterization
1999
A RANDOMIZED DOUBLE-BLIND TRIAL OF ORAL L-ARGININE FOR TREATMENT OF INTERSTITIAL CYSTITIS
KORTING G, SMITH S, WHEELER M, WEISS R, FOSTER H. A RANDOMIZED DOUBLE-BLIND TRIAL OF ORAL L-ARGININE FOR TREATMENT OF INTERSTITIAL CYSTITIS. Journal Of Urology 1999, 161: 558-565. PMID: 9915448, DOI: 10.1016/s0022-5347(01)61950-5.Peer-Reviewed Original ResearchConceptsL-arginine groupOral L-arginineNitric oxide synthase activityInterstitial cystitis symptomsInterstitial cystitis patientsOxide synthase activityPlacebo groupInterstitial cystitisL-arginineCystitis symptomsCystitis patientsUrinary nitric oxide synthase activityRandomized double-blind trialDouble-blind trialFrequency of painL-arginine treatmentGreater global improvementNitric oxide synthaseUrine of patientsUrine of controlsPain intensityOxide synthaseSynthase activityGlobal improvementPatients
1997
Improvement in Interstitial Cystitis Symptom Scores During Treatment With Oral L-Arginine
Smith S, Wheeler M, Foster H, Weiss R. Improvement in Interstitial Cystitis Symptom Scores During Treatment With Oral L-Arginine. Journal Of Urology 1997, 158: 703-708. DOI: 10.1016/s0022-5347(01)64297-6.Peer-Reviewed Original ResearchConceptsOral L-arginineL-arginineInterstitial cystitisInterstitial Cystitis Symptom ScoreNitric oxide synthase activityLower abdominal painInterstitial cystitis symptomsL-arginine treatmentOxide synthase activityNitric oxide synthaseSelf-controlled studyAbdominal painUrethral painUrinary frequencyCystitis symptomsSymptom scoresMethodsTen patientsOxide synthaseRelated symptomsImmunological responseNitric oxidePatientsSymptomsSignificant decreaseCystitisImprovement in Interstitial Cystitis Symptom Scores During Treatment With Oral L-Arginine
Smith S, Wheeler M, Foster H, Weiss R. Improvement in Interstitial Cystitis Symptom Scores During Treatment With Oral L-Arginine. Journal Of Urology 1997, 158: 703-708.. PMID: 9258064, DOI: 10.1097/00005392-199709000-00005.Peer-Reviewed Original ResearchConceptsOral L-arginineL-arginineInterstitial cystitisUrinary nitric oxide synthase activityInterstitial Cystitis Symptom ScoreOral L-arginine treatmentNitric oxide synthase activityLower abdominal painInterstitial cystitis symptomsMethods Ten patientsL-arginine treatmentOxide synthase activityNitric oxide synthaseSelf-controlled studyAbdominal painTEN patientsUrethral painUrinary frequencyCystitis symptomsSymptom scoresOxide synthaseRelated symptomsImmunological responseNitric oxidePatientsErosion of Malleable Penile Prosthesis into Bladder
Swana H, Foster H. Erosion of Malleable Penile Prosthesis into Bladder. Journal Of Urology 1997, 157: 2259-2260. PMID: 9146640, DOI: 10.1016/s0022-5347(01)64745-1.Peer-Reviewed Original Research
1996
Urinary Nitric Oxide Synthase Activity and Cyclic GMP Levels are Decreased with Interstitial Cystitis and Increased with Urinary Tract Infections
Smith S, Wheeler M, Foster H, Weiss R. Urinary Nitric Oxide Synthase Activity and Cyclic GMP Levels are Decreased with Interstitial Cystitis and Increased with Urinary Tract Infections. Journal Of Urology 1996, 155: 1432-1435. PMID: 8632605, DOI: 10.1016/s0022-5347(01)66301-8.Peer-Reviewed Original ResearchConceptsUrinary tract infectionCyclic GMP levelsUrinary nitric oxide synthase activityNitric oxide synthase activityInterstitial cystitisOxide synthase activityFemale patientsNOS activityTract infectionsGMP levelsFemale controlsFemale urinary tract infectionCyclic GMP/Certain disease processesIC patientsImmunologic responseUrinary tractSynthase activityDisease processL-argininePatientsNitric oxideL-citrullineGuanylyl cyclaseCyclic GMP